Irina U. Agoulnik

University of South Florida — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index3.0kcitations146works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(37), Prostate Cancer Treatment and Research(36), Pregnancy-related medical research(25), Cancer, Lipids, and Metabolism(10), Hormonal and reproductive studies(9)

Publications146 total

Structure–Activity Relationship Studies toward the Optimization of First-In-Class Selective Small Molecule Agonists of the GPCR Relaxin/Insulin-like Family Peptide Receptor 2
Journal of Medicinal Chemistry·2026
Abstract 4370217: Biased small molecule RXFP1 agonists ameliorate experimental pulmonary hypertension and RV hypertrophy
Circulation·2025
Abstract 4146456: Biased Activation of RXFP1 signaling via ML290 Attenuates Experimental Pulmonary Hypertension
Circulation·2024
DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich’s Ataxia
Biomolecules·2024Open Access
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology
Biochemical Pharmacology·2024· 6 citedOpen Access
Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer
Cancers·2023· 2 citedOpen Access
Supplementary Table 4 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary table 6 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Data from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 4 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary table 7 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 1 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary table 7 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Figures from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 3 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Figures from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary table 6 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 3 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 1 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
Supplementary Table 5 from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Alexander I. Agoulnik(18), Nancy L. Weigel(15), Michael Ittmann(9), Juan Marugán(8), D G Kieback(7), Myles C. Hodgson(6), Shu Feng(6), Noel Southall(6), Xin Hu(6), Marc Ferrer(6), Anna Frolov(5), Elena M. Kaftanovskaya(5), Jingbo Xiao(5), Xiaowen Tong(5), Courtney Myhr(5), William E. Bingman(4), Gustavo Ayala(4), Rile Li(4), Zaohua Huang(4), Brian A. Ho(4)